575 related articles for article (PubMed ID: 1501713)
1. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
Zhang Y; Heym B; Allen B; Young D; Cole S
Nature; 1992 Aug; 358(6387):591-3. PubMed ID: 1501713
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis.
Ramaswamy SV; Reich R; Dou SJ; Jasperse L; Pan X; Wanger A; Quitugua T; Graviss EA
Antimicrob Agents Chemother; 2003 Apr; 47(4):1241-50. PubMed ID: 12654653
[TBL] [Abstract][Full Text] [Related]
3. Novel selection for isoniazid (INH) resistance genes supports a role for NAD+-binding proteins in mycobacterial INH resistance.
Chen P; Bishai WR
Infect Immun; 1998 Nov; 66(11):5099-106. PubMed ID: 9784509
[TBL] [Abstract][Full Text] [Related]
4. Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC.
Nieto R LM; Mehaffy C; Creissen E; Troudt J; Troy A; Bielefeldt-Ohmann H; Burgos M; Izzo A; Dobos KM
PLoS One; 2016; 11(11):e0166807. PubMed ID: 27893795
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis.
Timmins GS; Master S; Rusnak F; Deretic V
Antimicrob Agents Chemother; 2004 Aug; 48(8):3006-9. PubMed ID: 15273113
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
Payton M; Auty R; Delgoda R; Everett M; Sim E
J Bacteriol; 1999 Feb; 181(4):1343-7. PubMed ID: 9973365
[TBL] [Abstract][Full Text] [Related]
7. Theoretical insights on the binding of isoniazid to the active site residues of Mycobacterium tuberculosis catalase-peroxidase.
Reyes YIA; Janairo GC; Franco FC
Tuberculosis (Edinb); 2019 Jan; 114():61-68. PubMed ID: 30711159
[TBL] [Abstract][Full Text] [Related]
8. Isonicotinic acid hydrazide conversion to Isonicotinyl-NAD by catalase-peroxidases.
Wiseman B; Carpena X; Feliz M; Donald LJ; Pons M; Fita I; Loewen PC
J Biol Chem; 2010 Aug; 285(34):26662-73. PubMed ID: 20554537
[TBL] [Abstract][Full Text] [Related]
9. A novel antioxidant gene from Mycobacterium tuberculosis.
Ehrt S; Shiloh MU; Ruan J; Choi M; Gunzburg S; Nathan C; Xie Q; Riley LW
J Exp Med; 1997 Dec; 186(11):1885-96. PubMed ID: 9382887
[TBL] [Abstract][Full Text] [Related]
10. The role of the novel exopolyphosphatase MT0516 in Mycobacterium tuberculosis drug tolerance and persistence.
Thayil SM; Morrison N; Schechter N; Rubin H; Karakousis PC
PLoS One; 2011; 6(11):e28076. PubMed ID: 22132215
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid in autoimmunity: a trigger for multiple sclerosis?
Nourbakhsh B; Stüve O
Ther Adv Neurol Disord; 2014 Sep; 7(5):253-6. PubMed ID: 25342979
[TBL] [Abstract][Full Text] [Related]
12. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Banerjee A; Dubnau E; Quemard A; Balasubramanian V; Um KS; Wilson T; Collins D; de Lisle G; Jacobs WR
Science; 1994 Jan; 263(5144):227-30. PubMed ID: 8284673
[TBL] [Abstract][Full Text] [Related]
13. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC
Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034
[TBL] [Abstract][Full Text] [Related]
14. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.
Cade CE; Dlouhy AC; Medzihradszky KF; Salas-Castillo SP; Ghiladi RA
Protein Sci; 2010 Mar; 19(3):458-74. PubMed ID: 20054829
[TBL] [Abstract][Full Text] [Related]
15. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.
Telenti A; Imboden P; Marchesi F; Lowrie D; Cole S; Colston MJ; Matter L; Schopfer K; Bodmer T
Lancet; 1993 Mar; 341(8846):647-50. PubMed ID: 8095569
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.
Cole ST; Brosch R; Parkhill J; Garnier T; Churcher C; Harris D; Gordon SV; Eiglmeier K; Gas S; Barry CE; Tekaia F; Badcock K; Basham D; Brown D; Chillingworth T; Connor R; Davies R; Devlin K; Feltwell T; Gentles S; Hamlin N; Holroyd S; Hornsby T; Jagels K; Krogh A; McLean J; Moule S; Murphy L; Oliver K; Osborne J; Quail MA; Rajandream MA; Rogers J; Rutter S; Seeger K; Skelton J; Squares R; Squares S; Sulston JE; Taylor K; Whitehead S; Barrell BG
Nature; 1998 Jun; 393(6685):537-44. PubMed ID: 9634230
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of isoniazid.
Timmins GS; Deretic V
Mol Microbiol; 2006 Dec; 62(5):1220-7. PubMed ID: 17074073
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
19. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
Scorpio A; Zhang Y
Nat Med; 1996 Jun; 2(6):662-7. PubMed ID: 8640557
[TBL] [Abstract][Full Text] [Related]
20. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis.
Heym B; Alzari PM; Honoré N; Cole ST
Mol Microbiol; 1995 Jan; 15(2):235-45. PubMed ID: 7746145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
